Cognitive deficits in pediatric-onset multiple sclerosis: what does the future hold?

Area of Science:

• Neurology
• Pediatric Neurology
• Neuroimmunology

Background:

• Pediatric-onset multiple sclerosis (MS) is a rare autoimmune disease affecting children and adolescents.
• Research into the specific characteristics and long-term outcomes of pediatric MS is still developing.
• Emerging studies indicate a significant prevalence of early cognitive deficits in this population.

Purpose of the Study:

• To review current research on cognitive functioning in pediatric-onset MS.
• To highlight similarities and differences compared to adult-onset MS.
• To identify key areas for future research, including treatment, neuroimaging, and disease-modifying factors.

Main Methods:

• Literature review of studies investigating cognitive deficits in pediatric-onset MS.
• Analysis of reported impairments in processing speed, visual-spatial processing, and language.
• Consideration of associated symptoms like fatigue and depression.

Main Results:

• Nearly one-third of pediatric MS patients exhibit cognitive deficits.
• Impairments are most prominent in processing speed, visual-spatial abilities, and language.
• Fatigue and depression are common and significantly affect functional outcomes.

Conclusions:

• Cognitive impairment is a notable feature of pediatric-onset MS, impacting daily functioning.
• Assessment and treatment strategies must address cognitive deficits, fatigue, and depression.
• Further research is crucial for understanding treatment efficacy, neuroimaging findings, and the influence of comorbidities, socioeconomic status, and race in pediatric MS.